NCT03764696

Brief Summary

Supplementary oxygen is routinely administered to patients, even those with adequate oxygen saturations, in the belief that it increases oxygen delivery. However, oxygen delivery depends not just on arterial oxygen content but also on perfusion. Maternal oxygen administration has been used in an attempt to lessen fetal distress by increasing the available oxygen from the mother. However, the effect of supplemental maternal oxygen therapy on fetal acid base status has been debated for more than seven decades. The investigators found the use of 2 L/min maternal oxygen during the second stage of labor did not adversely affect either the umbilical artery pH value or the fetal heart rate (FHR) pattern distribution.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 3, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 5, 2018

Completed
2.1 years until next milestone

Study Start

First participant enrolled

January 1, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

August 15, 2023

Status Verified

August 1, 2023

Enrollment Period

10 months

First QC Date

December 3, 2018

Last Update Submit

August 13, 2023

Conditions

Outcome Measures

Primary Outcomes (6)

  • Cord arterial pH values

    Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained.

    within 30 to 60 seconds of birth

  • Cord arterial partial pressure of oxygen

    Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained.

    within 30 to 60 seconds of birth

  • Cord arterial partial pressure of carbon dioxide

    Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained.

    within 30 to 60 seconds of birth

  • Cord venous pH values

    Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained.

    within 30 to 60 seconds of birth

  • Cord venous partial pressure of oxygen

    Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained.

    within 30 to 60 seconds of birth

  • Cord venous partial pressure of carbon dioxide

    Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained.

    within 30 to 60 seconds of birth

Secondary Outcomes (1)

  • Rate of abnormal fetal heart tracing

    at 1 minute after birth

Other Outcomes (5)

  • Rate of cesarean delivery

    at 1 minute after birth

  • Rate of assisted vaginal delivery

    at 1 minute after birth

  • Apgar score less than 7

    at 1 and 5 minutes after birth

  • +2 more other outcomes

Study Arms (2)

air, the first and second stage of labor

NO INTERVENTION

Patients randomized to the group will receive room air. The therapy will continue until after delivery

oxygen, the first and second stage of labor

EXPERIMENTAL

Patients randomized to the group will receive oxygen administered by high flow facemask oxygen at 10 L/min oxygen. The therapy will continue until after delivery

Device: tight-fitting simple facemask

Interventions

Oxygen will be administered by facemask at 10 L/min oxygen. The therapy will continue until after delivery

oxygen, the first and second stage of labor

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • at term (\>37 weeks, \<42 weeks), singleton, cephalic presentation, spontaneous or induced labor, normal labor, category I FHR tracings, 2 to 3 cm of cervical dilation in nulliparity, 1 to 2 cm of cervical dilation in multipara, informed consent.

You may not qualify if:

  • respiratory or cardiovascular disease, diabetes mellitus or insulin-treated gestational diabetes mellitus, hypertension or preeclampsia, oligohydramnios, fetal growth restriction, placental abruption, cephalopelvic disproportion, meconium-stained amniotic fluid, tachysystole, having received O2, uterine incision (myomectomy or perforation), anemia, fever, chorioamnionitis, tobacco or alcohol use, disorders in oxygen saturations, hypotension, uncomfortable with facemask.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Department of Obstetrics and Gynecology, PLA Strategic Support Force Characteristic Medical Center

Beijing, China

Location

Department of Obstetrics and Gynecology, Seventh Medical Center, Chinese PLA General Hospital

Beijing, China

Location

Department of Obstetrics and Gynecology, Sixth Medical Center, Chinese PLA General Hospital

Beijing, China

Location

Related Publications (2)

  • Chuai F, Dong T, Liu Y, Jiang W, Zhang L, Chen L, Chuai Y, Zhou Y. The effect of intrapartum prolonged oxygen exposure on fetal metabolic status: secondary analysis from a randomized controlled trial. Front Endocrinol (Lausanne). 2023 Jun 27;14:1204956. doi: 10.3389/fendo.2023.1204956. eCollection 2023.

    PMID: 37441500BACKGROUND
  • Chuai Y, Jiang W, Zhang L, Chuai F, Sun X, Peng K, Gao J, Dong T, Chen L, Yao Y. Effect of long-duration oxygen vs room air during labor on umbilical cord venous partial pressure of oxygen: a randomized controlled trial. Am J Obstet Gynecol. 2022 Oct;227(4):629.e1-629.e16. doi: 10.1016/j.ajog.2022.05.028. Epub 2022 May 14.

    PMID: 35580635BACKGROUND

MeSH Terms

Conditions

Fetal Distress

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Yunhai Chuai, Dr

    Sixth Medical Center, Chinese PLA General Hospital

    PRINCIPAL INVESTIGATOR
  • Fang Chuai

    Sixth Medical Center, Chinese PLA General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor of Obstetrics and Gynecology, Principal Investigator

Study Record Dates

First Submitted

December 3, 2018

First Posted

December 5, 2018

Study Start

January 1, 2021

Primary Completion

October 31, 2021

Study Completion

December 31, 2021

Last Updated

August 15, 2023

Record last verified: 2023-08

Locations